mounjaro patent expiration tirzepatide patent expiry Semaglutide generics hit Mounjaro sales,
Description
Modeled events included SAEs and treatment discontinuation
)
Tirzepatide, marketed as Mounjaro, is quickly becoming one of the most talked-about medications in the fight against stubborn weight gain
Appetite reduction is common
Both are incretin hormonesnaturally occurring substances released by the intestine in response to food intake
It is meant to be used in combination with diet and exercise
.png?v=4d024c233fd53ddcc0af6e3f6f5e3385)
Semaglutide can lower A1C by 1.52% on average
